STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
With a population of more than 100 million and a total drug consumption of more than 8 billion USD in 2023, the Vietnamese pharmaceutical market is quite attractive and has a lot of potential for production and business activities. The Ministry of Health said that 2024 is a key year, with the review and amendment
Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at a special seminar in Hà Nội. HÀ NỘI — Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at
The northern province of Thai Binh plans to build an industrial park to develop pharmaceutical and biological products, the first of its kind in Vietnam. Partners in the project are the Singapore-based Makara Capital Partners Pte. Ltd. and Sakae Corporate Advisory Pte. Ltd. and Vietnam’s Newtechco Group JSC. Under an MoU signed between provincial authorities
According to preliminary statistics from the General Department of Customs, in the first 6 months of 2024, our pharmaceutical import value reached 1.997.990.548 USD, an increase of 24,1% over the same period in 2023. According to preliminary statistics of the General Department of Customs, pharmaceutical import turnover in June 6 reached 2024 USD, down 348.711.261%
The total value of Vietnam’s pharmaceutical market is estimated at US$7 billion, but the industry faces challenges including low infrastructure and limited financial capacity, insiders have said. Vietnam’s pharmaceutical industry has experienced high growth over the past 10 years, with a compound annual growth rate of 7.3%. According to the Drug Administration of Vietnam under
Continuing the program of the 32nd session, on the afternoon of April 16, the National Assembly Standing Committee gave opinions on the Law Project amending and supplementing a number of articles of the Pharmacy Law. Reporting at the meeting, Minister of Health Dao Hong Lan said that compared to the current law, the draft Law
The version grants pharmaceutical business licenses to non-profit pharmaceutical entities that engage in commercial activities to ensure essential medicines reach a wider range of the population. HÀ NỘI — A revised version of the Law on Pharmaceuticals 2016 will be presented to the National Assembly for discussion and feedback during a legislative meeting from June
(HealthDay News) — Prenatal opioid exposure seems not to be associated with a meaningful increase in the risk for neuropsychiatric disorders in offspring, according to a study published online April 24 in The BMJ. Jiseung Kang, Ph.D., from the University of Oxford in the United Kingdom, and colleagues conducted a nationwide birth cohort study to
With the development of the global economy, the growth of the total population and the aging of society, the demand for drugs is increasing, and the market size of the global pharmaceutical industry will maintain growth. stable.In 2023, the total global pharmaceutical market is estimated to be approximately US$1,6 trillion. This is an increase of
According to the Resolution, the Government of Vietnam highly appreciates the Ministry of Health of Vietnam for taking charge and cooperating with ministries and central authorities in actively preparing and presenting Bills according to the Law on Promulgation of Legislative Documents 2015; and Agrees on the necessity of the development of the Law on amendments
Despite answering a number of state management requirements, the Pharmacy Law 2016 still displays certain inadequacies. Its amendments are supposed to provide patients with better access to new medication. To address inadequacies in the Law on Pharmacy 2016, the Government has already submitted a draft Law on Amendments for the Pharmacy Law 2016 to the
Vietnamese pharmaceutical market grew from $2.7 billion in 2015 to $7 billion in 2022 and is forecast to reach more than $10 billion by 2026. The Vietnamese pharmaceutical industry is seeing great advantages.People’s spending on health was increasingly high giving pharmaceutical enterprises great potential for development, said Associate Professor, PhD. Lê Văn Truyền, former Deputy
The European Commission’s Health Emergency Preparedness and Response Authority (HERA), working with the Belgian Presidency of the Council of the EU, have today launched the Critical Medicines Alliance at the margins of the informal EPSCO Council meeting of health ministers, as part of the actions to build a strong European Health Union. The Alliance brings
Under the People’s Committee of Ho Chi Minh City-approved project, the southern metropolis will have the country’s first largest medical and pharmaceutical industrial park. The city Department of Health today said that the municipal People’s Committee has just issued the Decision No. 657/QD-UBND to approve the Project ‘Developing Ho Chi Minh City’s pharmaceutical industry to
The top 10 businesses consist of Binh Thuan Plastic Group JSC, HD Securities Corporation, Orient Securities Corporation, Imedia Technology and Services JSC, SOL E&C Construction Investment JSC, Vietnam Vitadairy Milk JSC, Taseco Land Investment JSC, Stellapharm J.V. Co. Ltd., CNC Technology Solutions JSC, and Bee Logistics Corporation. The top 10 in the 2024 list of
The amended Law on Pharmacy is key in ensuring comprehensive and adequate healthcare resources for the people. HÀ NỘI — Deputy Prime Minister Trần Hồng Hà emphasised that the amended Law on Pharmacy must include regulations to support foreign pharmaceutical enterprises to invest in drug production and technology transfer in Vietnam. Speaking at a meeting
Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and cheapest prices during a meeting in Hanoi. Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and
Drugs that are commonly used and have large volumes must be subject to centralized national or local bidding and selection of qualified manufacturers, Deputy Prime Minister Tran Hong Ha requested. Chairing a meeting on the draft decree guiding the 2023 Bidding Law on contractor selection, Deputy Prime Minister Tran Hong Ha said that in addition
Only 42 new drugs out of 460 types circulated globally are available in Vietnam, due to long licensing procedures and time, affecting patients. On January 21, a representative of the Ministry of Health said that generic drug prices in Vietnam are low compared to countries in the ASEAN region (for most main treatment groups). While
It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains dominated by imported drugs and extend their international reach. Vietnam’s pharmaceutical market has significant potential. The Health Ministry
The Ministry of Health is drafting a Circular amending and supplementing a number of articles of Circular 29/2018/TT-BYT dated October 29, 10 of the Minister of Health regulating clinical drug trials. According to the provisions of Circular 29, regarding the legality of clinical drug trial records: The registration application and the content of the registration
Multinational corporations are giving priority to bringing more innovative medicines to Vietnam to tap into growing local demand. Pfizer plans to bring numerous innovative medicines to Vietnam over the next four years. This is in line with its global strategy, as the company has made significant progress towards launching 19 new products over an 18-month
Innovative pharmaceuticals are emerging as a game-changer reshaping the industry, which is urging Vietnamese authorities to have supporting policies to tap into new potential. At Pfizer, new innovative vaccines are being studied to keep abreast of new viruses and bacteria that threaten human lives and livelihoods. They include a two-in-one flu and coronavirus jab, and
By 2030, Vietnam will become a center for manufacturing or processing of, and transfer of technologies for, brand-name medicines in the ASEAN region. Under Prime Minister Decision 1165/QD-TTg, approving the National Strategy for development of the domestic pharmaceutical industry through 2030, with a vision toward 2045, it is expected that the domestic pharmaceutical industry’s production
The Ministry of Health has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry. The Ministry of Health (MOH) has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry.The
Medicine prices in Vietnam are in the lower range compared to those in other countries in the region, heard the Asian Federation for Pharmaceutical Sciences (AFPS) Conference 2023 that is taking place in Hanoi from November 8-10, 2023. Vice Health Minister Nguyen Thi Lien Huong speaks at the event (Photo: VNA) Themed “Collaboration for Breakthroughs
With a large population and a growing demand for pharmaceuticals, Vietnam currently ranks among the top 17 countries with the highest pharmaceutical industry growth rates globally. According to the Pharmaceutical Industry Development Program, by 2025, domestically produced drugs are expected to account for 75% of consumption and 60% of market value. Additionally, it is projected
New approaches for pharma-healthcare development in Vietnam were the main topic of discussion at a forum in Hanoi on July 20, 2023. At the event, held by the Dau tu (Investment Review) Newspaper, participants heard that the investment trend in the medicine and pharmacy fields changed a lot in the direction of focusing on innovation,
The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam less attractive to foreign investors. The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam
Vietnam has set a target of becoming a high-value pharmaceutical production center in the region under its strategy for the development of the pharmaceutical sector by 2030 with a vision to 2045. Under the strategy, which was approved by Deputy Prime Minister Tran Hong Ha on October 9, Vietnam will strive to develop its pharmaceutical
The pharmaceutical sector plays an important role in healthcare, meaning development goals must be established. Deputy Prime Minister Trần Hồng Hà made the statement on Wednesday afternoon after hearing a report on the draft National Strategy for the development of Việt Nam’s pharmaceutical sector by 2030. Hà said the draft strategy not only sets out
Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health Organisation, according to the National Strategy for Pharmaceutical Industry Development by 2023, with a vision toward 2045. Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health
LONDON, April 26, 2023 (Reuters) – Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere. The biggest overhaul of existing medical laws in two decades is aimed at ensuring all Europeans
The “Healthcare Innovation Forum”, a platform that brings together local and international experts to discuss and share experiences on innovative solutions in building a sustainable healthcare system worldwide and to drive the adoption of innovative approaches and technologies to transform healthcare in Vietnam. Diseases never stop developing, nor does innovation to deal with these obstacles.
The Ho Chi Minh City Department of Health is seeking feedback on the plan to construct a 300-hectare pharmaceutical industrial park during the 2025-30 period, a step to prepare for the city’s export of medical products in the future. People work inside a medical laboratory in Ho Chi Minh City – Photo: DUYEN PHAN / Tuoi
The Circular is an important legal basis for attracting investment activities and transferring technology for drug production, especially original brand name drugs, patented drugs, specialized drugs, special treatments, and prescription drugs. generic drugs in the form of high-tech dosage forms, vaccines, reference biological products, and similar biological products according to the orientations in the “Program
Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming
On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;
Vietnam has set its sights on becoming a high-value pharmaceutical production hub within the region. Deputy Prime Minister Trần Hồng Hà recently backed a decision that has been hailed a significant milestone in Vietnam’s pharmaceutical sector. Signed on October 9, Decision No. 1165/QĐ-TTg has approved the National Strategy for developing Vietnam’s pharmaceutical industry until 2030,
The Ministry of Health is drafting a Circular promulgating a list of drugs, testing supplies, and medical equipment eligible for price negotiation and stipulating the process and procedures for selecting contractors for applicable bidding packages. form of price negotiation. According to the draft, the construction of the drug list is applied in the form of
It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains being dominated by imported drugs and extend their international reach.Vietnam’s pharmaceutical market has significant potential. The Ministry of
As one of seven generic drug manufacturers selected by MPP and becoming a sub-licensee of Shionogi – a Japanese pharmaceutical manufacturer to produce of XOCOVA™ drug, generic version. Stellapharm is honored and proud to have contributed to repelling the COVID-19 pandemic with drugs. This is the third oral product in the world to be recognized
By Mr. Ong Van Dung, General Director, Stellapharm Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with European
Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars. Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and
On February 21, 2022, Stellapharm officially signed a contract with MPP (Medicines Patent Pool), a UNITED NATIONS-backed public health organization to become the only manufacturer in Vietnam allowed to produce a generic version of Pfizer’s oral COVID-19 treatment, nirmatrelvir, which will be co-packaged with ritonavir, under the voluntary licensing agreement between Pfizer and the MPP.
Despite having a good market, the pharmaceutical manufacturing in Vietnam still faces many difficulties. This difficulty comes from industry competition, world competition and technological development. In order for the pharmaceutical manufacturing to develop, what should pharmaceutical enterprises do? Overview of Vietnam’s pharmaceutical manufacturing industry 2023.The market for the pharmaceutical industry in Vietnam is relatively active:The
20 January 2022 Geneva – The Medicines Patent Pool (MPP) announced today that it has signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and
[Updated to July 2021] The results of the trial demonstrate the safety, tolerability, and antiviral efficacy of molnupiravir to reduce replication of SARS-CoV-2 and accelerate clearance of infectious virus and support ongoing trials of molnupiravir to prevent progression of COVID-19 and eliminate onward transmission of SARS-CoV-2. After more than one year into the coronavirus disease
Since the beginning of February this year, many consignments of Stella's pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.
Lesovir is manufactured by its EU-GMP facility and distributed via exclusive distributor, Khuong Duy Pharma Co., Ltd. The product is a fixed-combination preparation of Ledipasvir 90 mg and Sofosbuvir 400 mg) is an oral drug used for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection which are common types in Asia including Vietnam.
This will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.
Due to our strategic development of the Company, we are pleased to announce the change of Company Name: STADA - VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019. Address, Tax code, Telephone/Fax Number remains unchanged.
“Accrediting the fifth EU-GMP is one of our commitment on maintaining highest EU standards and quality of products with affordable prices” said by Choo Yan Ho, the Chairman.
On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1
On 06 January 2015, STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), was appreciated by Ministry of Health, Labour and Welfare (the "MHLW") issued the certificate of Japan GMP for the product of Soleton 80 with its composition and strength: Zaltoprofen 80 mg
On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued
Partamol 150 Supp. (paracetamol 150 mg) is reserved for symptomatic treatment of mild to moderate pain and/or feverish states in infants weighing 8 to 12 kg (approximately 6 to 24 months).
S-Profen 400 (Dexibuprofen 400 mg) is an anti-inflammatory and anti-rheumatic product, non-steroids, has an analgesic, anti-inflammatory and anti-pyretic effect in osteoarthritis.
Stadolac 200 (etodolac 200mg) is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits antiinflammatory, analgesic, and antipyretic activities. It is indicated for the management of pain in osteoarthritis, rheumatoid arthritis.
Naproflam 500 (Naproxen 500 mg) is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties. Naproxen inhibits prostaglandin synthetase (as do other NSAIDs).
Rupatadine STELLA 10 mg (Rupatadine fumarate) is designed for symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 years of age).
PARTAMOL 250 EFF. contains paracetamol helps to analgesia and antipyresis. Paracetamol lowers body temperature in patients with fever but rarely lowers normal body temperature.
Ferolina (Zinc fumarate, spirulina powder, folic acid, vitamin B12) helps reduce the risk of zinc deficiency anemia, supports the process of blood formation in adults and children over 10 years old.
Supplements folic acid for the body. Supports increasing blood formation. Helps reduce anemia due to folic acid deficiency,
CoQ10-STELLA contains Coenzyme Q10 and black pepper extract, supports antioxidant activity and promotes cardiovascular health in adults. This product is not approved therapeutic claims.
Rutin-C STELLA (Rutin trihydrate combined with ascorbic acid) helps increase vascular endurance, supports antioxidant activity and promotes cardiovascular health in adults.
ZinDcal (Calcium, Magnesium, Zinc, Vitamin D3) supports enhanced calcium absorption, helps strengthen bones and teeth, aids in height development, reduces the risk of rickets in children, and decreases the risk of osteoporosis in adults.
Helix STELLA containing dried ivy leaf extract (Hedera helix L.) is used for adults and children above 1 in dry cough, productive cough, cough due to weather change, sore throat, bronchitis. This product is health supplement, not approved therapeutics claims.
The main pharmacodynamic property of ivabradine in humans is a specific dose dependent reduction in heart rate. Ivabradine does not influence intracardiac conduction, contractility (no negative inotropic effect) or ventricular repolarization.
In both healthy subjects and patients with hypercholesterolaemia, pravastatin sodium lowers the following lipid values: total cholesterol, LDL-cholesterol, apolipoprotein B, VLDL-cholesterol and riglycerides; while HDL-cholesterol and apolipoprotein A are elevated.
In patients with essential hypertension, a single oral daily dose of cilnidipine showed a hypotensive action that maintained for 24 hours and was still evident early in the next morning.
Lacidipine is indicated for the treatment of hypertension as monotherapy or in combination with other antihypertensive agents such as beta-blockers, diuretics and ACE inhibitors.
Rebagastrin (Rebamipide 100 mg) belongs to the group of drugs used for treatment gastric and duodenal ulcers and gastroesophageal reflux disease in adults.
Tefostad T300 (Tenofovir disoproxil fumarate) is used in conjunction with other antiretroviral agents (should not be used alone) in the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, post-exposure prophylaxis of HIV infection and in treatment of chronic hepatitis B in adults.
Metformin STELLA 850 mg is indicated in treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
Felodipine is used for management of hypertension and prophylaxis of stable angina pectoris. It has anti-anginal and anti-ischemic effects due to improved myocardial oxygen supply/demand balance.
Nifedipin T20 retard is used in treatment of the prophylaxis of angina, if especially element vasospastic as Prinzmetal's angina and treatment of hypertension.
Stadovas 5 CAP (Amlodipine) is used to treat hypertension, angina. The drug may be used as monotherapy or in combination with other antianginal medicinal products.
Bisostad 5 (Bisoprolol fumarate) is used to treat hypertension and angina pectoris. It is also used as an adjunct to standard therapy in patients with stable chronic heart failure.
Bisoprolol is given as the fumarate in the management of hypertension and angina pectoris. The drug is also used as an adjunct in standard therapy in patients with stable chronic heart failure.
Xelostad 10 (Rivaroxaban) is used for prevention of venous thromboembolism (VTE) in adult patients, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
Simvastatin and ezetimibe combination along with a proper diet to help lower "bad" cholesterol and fats (such as LDL-C, triglycerides) and increase "good" cholesterol (HDL-C) in the blood to help reduces the risk of heart disease, an intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.
Irbeplus HCT is a combination of an angiotensin-II receptor antagonist (Irbesartan) and a thiazide diuretic (Hydrochlorothiazide). This combination has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.
Amiodarone is an antiarrhythmic drug used to treat and prevent certain types of arrhythmias. These arrhythmias include ventricular tachycardia, ventricular fibrillation, and wide QRS tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. However, evidence in cardiac arrest is limited.
Castella 90 (Ticagrelor) is co-administered with acetylsalicylic in the prevention of atherothrombotic events in adult patients with acute coronary syndromes and with history of myocardial infarction and a high risk of developing an atherothrombotic event.
Statripsine (Alphachymotrypsine) is used for treatment of post traumatic, post-operative oedema, burn. The drug is orally or sublingually administered.
Zynadex 40 is used to treat various types of inflammation and edema, to reduce swelling caused by bruising, fractures, traumatic brain injury, postoperation, post-traumatic soft tissue swelling, and acute thrombophlebitis.
Enaplus HCT 5/12.5 containing enalapril maleate and hydrochlorothiazide is a medicine used in hypertension treatment.
Ezecept 20/10 containing ezetimibe and atorvastatin, is a lipid-lowering agent that selectively inhibits the intestinal absorption of cholesterol and related phytosterols and inhibits endogenous cholesterol synthesis.
Azoltel 400 contains albendazole, a benzimidazole carbamate derivative which is structurally related to hiabendazole and mebendazole. It has a wide spectrum of activity against intestinal nematodes.
Racecadotril granules for oral suspension is prescribed for complementary symptomatic treatment of acute diarrhoea in infants (older than 3 months) and in children together with oral rehydration.
Gliptinestad (Sitagliptin 50 mg) is indicated to improve glycaemic control in adult patients with type 2 diabetes mellitus.
Zecein 80 (Drotaverine) belongs to the group of smooth muscle spasmolytic agent, is normally indicated for treatment of pain syndromes of various organs: gastrointestinal, biliary, urogenital and vascular systems.
Alumastad contains dried aluminum hydroxide gel and magnesium hydroxide which are antacids pain reliever and indigestion discomfort by neutralizing acid, reducing the excess acidity in the stomach.
Bicimax is used for supplementation of deficiencies of the vitamins B complex, vitamin C, calcium and magnesium: e.g., prolonged stress, prolonged infection and fever, intestinal diseases, gastrectomy, alcohol abuse, ...
Calcium STELLA 500 mg effervescent tablets with active ingredient calcium are used in the prevention and treatment of calcium deficiency, preventing osteoporosis, rickets... for adults and children.
Pravitce contains calcium and vitamin C. Its main use is to supplement these two substances for people suffering from nutritional deficiencies, during pregnancy, lactation, adolescents during growth, and the elderly.
Elnitine is used for supplementation of calcium and magnesium in for patients in convalescence, stress, elderly patients, menopausal women, children in growth.
Sertraline is an antidepressant (selective serotonin reuptake inhibitors - SSRIs). Lexostad 50 (Sertraline) is commonly used for major depressive episodes, panic disorder, obsessive compulsive disorder (OCD). It may also be used for other conditions as determined by your healthcare provider.
Sulpistad 200 (Amisulpride) is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
Quetiapine STELLA 200 mg is indicated for treatment of schizophrenia, treatment of bipolar disorder, ..
Paracetamol is an effective alternative to aspirin as an analgesic-antipyretic agent; however, it is not a useful agent to treat inflammatory conditions. Paracetamol lowers body temperature in patients with fever but rarely lowers normal body temperature.
Partamol-Cafein is fixed-combination of paracetamol and caffeine that is indicated for treatment of most painful and febrile conditions, for example, headache, including migraine, backache, toothache.....
Aldenstad plus (Alendronic acid; Cholecalciferol) is commonly used for treatment of bone diseases. It is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency. It reduces the risk of vertebral and hip fractures.
Eperistad (Eperisone hydrochloride) is effective in improving myotonic symptoms such as stiffness of shoulders, cervical pain, muscle contraction type headache, dizziness, lower back pain and rigidity of extremeties which may accompany encephalomyelopathies, cervical syndrome, periarthritis of the shoulder or lumbago.
Myopain 150 (tolperisone hydrochloride) is used for treatment of post-stroke spasticity in adults. It works on the spinal cord and centers in the brain to relieve contraction or muscle stiffness without a decrease in strength.
Zanastad reduces motor neurons stimulation on the spinal cord, therefore reducing muscle spasm and not producing excessive muscle weakness.
Molnupiravir is indicated for the treatment of mild to moderate COVID-19 disease in adults with a positive diagnostic test for SARS-CoV-2 and with at least one risk factor for severe disease progression.
Flustad 75 (Oseltamivir) is an antiviral drug for systemic use indicated for treatment and prevention of influenza in adults and children (including full term neonates) following contact with an infected person influenza but not a substitute for influenza vaccination.
Stadfovir 25 (Tenofovir alafenamide fumarate) is indicated for the treatment of chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg).
Lamzidivir is used in antiretroviral combination therapy for the treatment of HIV infection.
Lamone 150 (Lamivudine) is indicated as part of antiretroviral combination therapy for the treatment of HIV infected adults and children.
Spirastad Plus is a fixed-combination preparation of spiramycin and metronidazole, which is indicated for treatment and prevention of buccodental infection.
Prednisolone is a synthetic, anti-inflammatory glucocorticoid. At high doses, this medicine has a dampening effect on the immune response.
Deflazacort is in a class of medications called corticosteroids. Its antiinflammatory and immunosuppressive effects are used in treating asthma, arthritis, immune suppression in transplantation.
Methylprednisolone is a synthesis glucocorticoid. The drug Stadsone 16 is mainly used as treatment for some diseases including causes due to hematology, allergies, inflammation, cancer and autoimmune.
Pranstad 1 (Repaglinide) is used as monotherapy as an adjunct for the management of type 2 diabetes mellitus in adults whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise.
Mopristad 5 (Mosapride citrate) is indicated for the treatment of gastrointestinal symptoms (heartburn, nausea/vomiting) associated with functional dyspepsia (chronic gastritis).
Smetstad (Diosmectite) is used in treatment of painful symptoms of oesophagitis and gastroenteritis, supporting of electrolyte fluid therapy in chronic and acute diarrhoea, particularly in children.
Almasane is a balanced mixture of two antacids and an antiflatulent-agent simethicone, belongs to the group of drugs for acid related disorders, normally used for the symptomatic relief of dyspepsia, heartburn, flatulence.
Pantostad 20 (Pantoprazole) is indicated for Gastro-oesophageal reflux disease (GORD), peptic ulcer disease, prophylaxis for NSAID-associated ulceration, Zollinger-Ellison syndrome.
Arastad 20 (Leflunomide) is used for treatment of active rheumatoid arthritis in adults, active psoriatic arthritis. It is used for adult patients (18 years of age and older).
Take BK-1 (levonorgestrel) emergency contraceptive pill orally as soon as possible within 72 hours after unprotected intercourse or a known or suspected contraceptive failure. Efficacy is better if the tablet is taken as soon as possible after unprotected intercourse.
Dequalinium chloride is an antiinfectives and antiseptics excl. combinations with corticosteroids, indicated for the treatment of bacterial vaginosis.
Stadmazol 500 vaginal tablet contains clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity.
Bamstad (Bambuterol hydrochloride) is indicated for management of asthma, bronchospasm and/or reversible airways obstruction in adults.
Bilazin 20 (Bilastine) is indicated in symptomatic treatment of allergic rhino-conjunctivitis (seasonal or perennial) and urticaria. The drug does not cause drowsiness.
Amxolstad 30 (Ambroxol hydrochloride) has mucokinetic and expectorant properties in acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions.
Amxolstad 60 mg/10 ml (Ambroxol hydrochloride) has mucokinetic and expectorant properties in acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions.
Stacytine 200 GRA containing acetylcysteine is for the treatment of bronchial secretion disorders, in particular during acute bronchial affections: acute bronchitis and acute episode of chronic bronchopneumopathies.
Betamethasone combined with Dexchlorpheniramine maleate is indicated for adults and children over 6 years old in symptomatic treatment of seasonal and perennial allergic rhinitis, symptomatic treatment of acute hives.
Stadgentri is a topical cream combining the anti-inflammatory, antipruritic actions of betamethasone with the antifungal activity of clotrimazole and the broad-spectrum antibiotic activity of gentamicin sulfate.
Flucistad topical cream (Fusidic acid) is used alone or in combination with systemic treatment in dermatitis caused by susceptible strains of bacteria. The drug has no effect on fungi.
Acyclovir STELLA Cream is used for treatment of Herpes simplex virus infection of the skin including initial and recurrent genital herpes and herpes labialis.
">
